Paul van Damme
Directeur/Membre du Conseil chez XORTX THERAPEUTICS INC.
Fortune : 18 308 $ au 31/05/2024
Profil
Paul Joseph van Damme currently works at Ontario Genomics Institute, as Director, Wildlaw Capital Markets, Inc., as Managing Director, XORTX Therapeutics, Inc., as Independent Director from 2018, and WD Capital Markets, Inc., as Managing Director.
Mr. van Damme also formerly worked at Quest PharmaTech, Inc., as Independent Director from 2012 to 2015, ZipLocal, Inc., as Chief Financial Officer & Director from 2012 to 2016, Insception Biosciences, Inc., as Director, Structural Genomics Consortium, as Chief Financial Officer, Secretary & Director from 2012 to 2019, Ontario Genomics Institute (Private Equity), as Director, XORTX Pharma Corp., as Director, OncoQuest, Inc., as Director from 2015 to 2020, Aptose Biosciences, Inc., as Chief Financial Officer from 2004 to 2005, Vasogen, Inc., as CFO in 2007, Bradmer Pharmaceuticals, Inc., as Chief Financial Officer from 2007 to 2018, Allelix Biopharmaceuticals, Inc., as Chief Financial Officer, NXA, Inc., as Chief Financial Officer, Crosswinds Holdings, Inc., as Chief Financial Officer from 2013 to 2015, PricewaterhouseCoopers, Inc., as Principal, Laidlaw, Inc. (Connecticut), as Chief Financial Officer, Canada Systems Group Ltd., as Chief Financial Officer in 1991, Junior Achievement of Central Ontario, as Chief Financial Officer, Ellipsiz Communications Ltd., as Chief Financial Officer from 2011 to 2015, Galaxy Digital Holdings Ltd., as Chief Financial Officer, and Mind Medicine (MindMed), Inc., as Chief Financial Officer in 2020.
Mr. van Damme received his Masters Business Admin degree from Rotman School of Management and undergraduate degree from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
XORTX THERAPEUTICS, INC.
0,36% | 04/03/2024 | 7 110 ( 0,36% ) | 18 308 $ | 31/05/2024 |
Postes actifs de Paul van Damme
| Sociétés | Poste | Début |
|---|---|---|
| XORTX THERAPEUTICS INC. | Directeur/Membre du Conseil | 25/01/2018 |
Wildlaw Capital Markets, Inc.
 Wildlaw Capital Markets, Inc. Investment ManagersFinance Wildlaw Capital Markets, Inc. provides investment advice. The private company is based in Toronto, Canada. | Corporate Officer/Principal | - |
| Ontario Genomics Institute | Directeur/Membre du Conseil | 20/10/2010 |
WD Capital Markets, Inc.
 WD Capital Markets, Inc. Finance/Rental/LeasingFinance WD Capital Markets, Inc. provides equity and debt financing services. The private company is based in Toronto, Canada. | Corporate Officer/Principal | - |
Anciens postes connus de Paul van Damme
| Sociétés | Poste | Fin |
|---|---|---|
| MIND MEDICINE (MINDMED) INC. | Directeur Financier/CFO | 01/04/2020 |
OncoQuest, Inc.
 OncoQuest, Inc. BiotechnologyHealth Technology OncoQuest, Inc. is a Canadian biotechnology company, which engages in developing and commercializing products for the treatment of cancer. The company is headquartered in Edmonton, Canada. | Directeur/Membre du Conseil | 01/02/2020 |
Structural Genomics Consortium
 Structural Genomics Consortium Miscellaneous Commercial ServicesCommercial Services The Structural Genomics Consortium is a non-profit organization that accelerates research by sharing all of its research output with the scientific community without any restrictions. The private company is based in Headington, UK. The British company has created an open collaborative network of scientists in hundreds of universities worldwide and nine pharmaceutical companies. The company was founded by Pär Nordlund. | Directeur Financier/CFO | 31/05/2019 |
| GALAXY DIGITAL HOLDINGS LTD. | Directeur Financier/CFO | 31/07/2018 |
Bradmer Pharmaceuticals, Inc.
 Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Directeur Financier/CFO | 01/07/2018 |
Formation de Paul van Damme
| Rotman School of Management | Masters Business Admin |
| University of Toronto | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| QUEST PHARMATECH INC. | Commercial Services |
| XORTX THERAPEUTICS INC. | Health Technology |
| GALAXY DIGITAL HOLDINGS LTD. | Commercial Services |
| MIND MEDICINE (MINDMED) INC. | Health Technology |
| Entreprise privées | 19 |
|---|---|
PricewaterhouseCoopers, Inc.
 PricewaterhouseCoopers, Inc. Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers, Inc. is a South African company that provides accounting, auditing, and bookkeeping services. The company is based in Sunninghill, South Africa. | Commercial Services |
Bradmer Pharmaceuticals, Inc.
Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Commercial Services |
Vasogen, Inc.
 Vasogen, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are research and commercialization of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. It's lead product, the Celacade System, is designed to activate the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade has received European regulatory approval under the CE Mark for chronic heart failure and is currently being marketed in Europe by Grupo Ferrer Internacional, S.A. Celacade is also in late-stage development for the treatment of chronic heart failure in the United States. It is also developing a new class of drugs for the treatment of certain neuro-inflammatory disorders. VP025 is the lead drug candidate from this new class. | Health Technology |
| Canada Systems Group Ltd. | |
| Ontario Genomics Institute | |
NXA, Inc.
 NXA, Inc. Other Metals/MineralsNon-Energy Minerals NXA, Inc. engages in the exploration of base materials and precious metals. The company was founded on April 1, 1996 and is headquartered in Toronto, Canada. | Non-Energy Minerals |
Ontario Genomics Institute (Private Equity)
 Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Finance |
| Allelix Biopharmaceuticals, Inc. | Health Technology |
| Laidlaw, Inc. (Connecticut) | Transportation |
ZipLocal, Inc.
 ZipLocal, Inc. Financial ConglomeratesFinance ZipLocal, Inc. is a development stage company. It operates through Canada geographical segments. The company was founded on August 22, 2005 and is headquartered in Toronto, Canada. | Finance |
Junior Achievement of Central Ontario
 Junior Achievement of Central Ontario Investment Trusts/Mutual FundsMiscellaneous Junior Achievement of Central Ontario educates young people about business. It focuses on work readiness, financial literacy and entrepreneurship, giving students the confidence and skills they need to become the next generation of business and community leaders. The company was founded by Horace A. Moses in 1919 and is headquartered in Toronto, Canada. | Miscellaneous |
Insception Biosciences, Inc.
 Insception Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Insception Biosciences, Inc. engages in the research and development of stem cell-based treatments. It also provides cord blood banking services. The company was founded by Robert Casper in 1996 and is headquartered in Mississauga, Canada. | Commercial Services |
Wildlaw Capital Markets, Inc.
Wildlaw Capital Markets, Inc. Investment ManagersFinance Wildlaw Capital Markets, Inc. provides investment advice. The private company is based in Toronto, Canada. | Finance |
Structural Genomics Consortium
Structural Genomics Consortium Miscellaneous Commercial ServicesCommercial Services The Structural Genomics Consortium is a non-profit organization that accelerates research by sharing all of its research output with the scientific community without any restrictions. The private company is based in Headington, UK. The British company has created an open collaborative network of scientists in hundreds of universities worldwide and nine pharmaceutical companies. The company was founded by Pär Nordlund. | Commercial Services |
Crosswinds Holdings, Inc.
 Crosswinds Holdings, Inc. BiotechnologyHealth Technology Crosswinds Holdings, Inc. is a private equity and asset management company, which engages in the investment in the financial services sector. It operates through the following segments: Primary Insurance, Reinsurance, and Asset Management. The Primary Insurance segment invests in the Monarch National Insurance Company which is a property and casualty insurance carrier. The Reinsurance segment provides specialty reinsurance through Crosswinds Re. The Asset Management segment operates as an investment advisor through Crosswinds AUM LLC. The company was founded by John Fenbar Driscoll on March 29, 2005 and is headquartered in Toronto, Canada. | Health Technology |
OncoQuest, Inc.
OncoQuest, Inc. BiotechnologyHealth Technology OncoQuest, Inc. is a Canadian biotechnology company, which engages in developing and commercializing products for the treatment of cancer. The company is headquartered in Edmonton, Canada. | Health Technology |
XORTX Pharma Corp.
 XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Health Technology |
Ellipsiz Communications Ltd.
 Ellipsiz Communications Ltd. Specialty TelecommunicationsCommunications Ellipsiz Communications Ltd. engages in the operations support for communication service provider. It also includes mobile network providers, fixed line telephone operators, cable operators, and internet service providers. The company was founded on April 1, 1996 and is headquartered in Markham, Canada. | Communications |
WD Capital Markets, Inc.
WD Capital Markets, Inc. Finance/Rental/LeasingFinance WD Capital Markets, Inc. provides equity and debt financing services. The private company is based in Toronto, Canada. | Finance |
